Press Releases

ZHOUSHAN, China, June 14, 2024 /PRNewswire/ -- This summer, the 4th Zhejiang Ocean Games were grandly held on the picturesque island of Shengsi, attracting over 7,000 marine sports enthusiasts from across the country. Spanning from May to June, this month-long competition has significantly boosted attention towards Zhejiang's burgeoning marine economy and island tourism.

... (continue reading...)

SHANGHAI, June 15, 2024 /PRNewswire/ -- At the SNEC PV Power Expo, Beny stood out among over 3,500 participating companies to win the prestigious SNEC "Top 10 Highlights" Terawatt Diamond Award with its self-developed Smart Remote Disconnect Switch, BYSS-63MT. This accolade not only affirms Beny's technical prowess but also highlights its innovation and leadership in the PV field. The onsite product launch allowed industry experts and attendees to gain deeper insights... (continue reading...)

QINGDAO, China, June 15, 2024 /PRNewswire/ -- As UEFA EURO 2024™ kicked-off last night, Hisense, a leading global home appliance and consumer electronics brand, celebrated its involvement as official partner of UEFA EURO 2024™ and official tournament VAR screen provider with the launch of its 'Beyond Glory' Murals Campaign.

Ensuring fans across the... (continue reading...)

BEIJING, June 15, 2024 /PRNewswire/ -- In Beijing, the essay topic for the English test of this year's gaokao focuses on the 75th anniversary of the founding of the People's Republic of China. Chinese middle school student Li Hua was asked to offer some suggestions to his foreign friend Jim, who wants to write a piece on this subject. To help enlighten Jim as well as those who are interested in China's development, the Global Times invited several foreign experts and... (continue reading...)

Patients who received nipocalimab 15 mg/kg demonstrated a greater than 70 percent relative average improvement on the primary endpoint compared to patients who received placebo

Sjögren's disease is a chronic, debilitating, and prevalent autoantibody disease with no approved advanced treatments

VIENNA, June 15, 2024 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announces patients treated with nipocalimab demonstrated statistically significant (P=0.002) and clinically... (continue reading...)